REALASA: Real-world effectiveness assessment of first-line 5-ASA for the treatment of Ulcerative Colitis in Sweden

被引：0
|
作者：
Christophersen, B. [1 ]
Nielsen, L. [2 ]
Landeira, M. [3 ]
Guedes, S. [4 ]
机构：
[1] Ferring Pharmaceut Inc, Med Affairs, Copenhagen, Denmark
[2] Ferring Pharmaceut Inc, Stat, Copenhagen, Denmark
[3] Ferring Pharmaceut Inc, Hlth Econ & Outcomes Res, Copenhagen, Denmark
[4] Ferring Pharmaceut Inc, Real World Evidence, Copenhagen, Denmark
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0907
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0733
引用
收藏
页码：I1423 / I1423
页数：1
相关论文
共 50 条
  • [41] Efficacy of Oral Mesalamine Monotherapy (5-ASA) versus Combination Oral Mesalamine Plus Proton Pump Inhibitor (5-ASA/PPI) Therapy in the Treatment of Ulcerative Colitis (UC)
    Lichtenstein, Gary
    Marchioni, Renee
    Blonski, Wojciech
    Mudireddy, Prashant
    Buchner, Anna
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S630 - S631
  • [42] Cost-effectiveness of surveillance for ulcerative colitis-associated colorectal cancer in the setting of 5-ASA maintenance therapy
    Rubenstein, Joel H.
    Waljee, Akbar K.
    Velayos, Fernando S.
    Ladabaum, Uri
    Higgins, Peter D.
    GASTROENTEROLOGY, 2008, 134 (04) : A112 - A112
  • [43] Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis
    Gros, Beatriz
    Goodall, Mairi
    Plevris, Nik
    Constantine-Cooke, Nathan
    Elford, Alexander T.
    O'Hare, Claire
    Noble, Colin
    Jones, Gareth-Rhys
    Arnott, Ian D.
    Lees, Charlie W.
    JOURNAL OF CROHNS & COLITIS, 2023,
  • [44] Real-World Evidence on the Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis in Lebanon
    Sharara, Ala I.
    Alrazim, Ayman
    Saniour, Philippe
    Daniel, Fady
    Rached, Antoine Abou
    Bahr, Abbas
    Azar, Cecilio
    Geagea, Antoine
    Ghoubar, Marcelle
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S858 - S859
  • [45] REAL-WORLD EFFECTIVENESS OF TOFACITINIB IN ULCERATIVE COLITIS; A MULTI-CENTER STUDY
    Patel, Anish
    Fenster, Marc
    Bader, Geoffrey
    Dimopoulos, Christina
    Deepak, Parakkal
    Ungaro, Ryan C.
    Ciorba, Matthew A.
    Yarur, Andres J.
    Hirten, Robert
    Christophi, George P.
    Khatiwada, Aava
    Lin, Bixuan
    Colombel, Jean Frederic
    Ha, Christina
    Cohen, Benjamin L.
    Pekow, Joel R.
    Beniwal-Patel, Poonam M.
    Syal, Gaurav
    GASTROENTEROLOGY, 2019, 156 (06) : S168 - S169
  • [46] Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study
    Ungaro, R.
    Fenster, M.
    Dimopoulos, C.
    Patel, A.
    Deepak, P.
    Syal, G.
    Yarur, A.
    Hirten, R.
    Christophi, G.
    Khatiwada, A.
    Lin, B.
    Colombel, J. -F.
    Ha, C.
    Weisshof, R.
    Beniwal-Patel, P.
    Cohen, B.
    Pekow, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S274 - S275
  • [47] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN THE UNITED STATES OF AMERICA
    Burbage, Sabree
    Harvey, Niamh
    Godwin, Bridget
    Meadows, Rachael
    Knight, Hannah
    Zhao, Ruizhi
    Kachroo, Sumesh
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S86 - S87
  • [48] Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
    Lair-Mehiri, Loriane
    Stefanescu, Carmen
    Vaysse, Thibaut
    Laharie, David
    Roblin, Xavier
    Rosa, Isabelle
    Treton, Xavier
    Abitbol, Vered
    Amiot, Aurelien
    Bouguen, Guillaume
    Dib, Nina
    Fumery, Mathurin
    Pariente, Benjamin
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Simon, Marion
    Viennot, Stephanie
    Bouhnik, Yoram
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (03) : 268 - 273
  • [49] REAL-WORLD TREATMENT PATTERNS AND DRUG-RELATED COSTS OF ULCERATIVE COLITIS: A RETROSPECTIVE COHORT STUDY IN SWEDEN
    Szilcz, M.
    Mulugeta, Gonzalez E.
    Naghipour, P.
    Toghanian, S.
    VALUE IN HEALTH, 2024, 27 (12) : S82 - S82
  • [50] Azathioprine is more effective than oral 5-ASA in the treatment of steroid-dependent ulcerative colitis.
    Ardizzone, S
    Samolvico, F
    Bollani, S
    Imbesi, V
    Colombo, E
    Porro, GB
    GASTROENTEROLOGY, 2001, 120 (05) : A127 - A127
12345